EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Pharma Email Marketing Europe: Personalized Campaigns for C-Suite Leads

    The pharmaceutical industry is a very competitive industry and to reach the decisionmakers a focused and strategic marketing strategy is necessary Conventional marketing is not often precise enough to reach executives that drive buying alliances and strategic relationships Here the pharma email marketing has come to play as a potent instrument of relationship establishment with the key stakeholder...

    10 Effective Strategies to Reduce Water Waste in Pharmaceutical Manufacturing

    Water is a resource of great concern to pharmaceutical manufacturing since it is essential in the cleaning of equipment used in manufacturing operations as well as in drug formulations Nevertheless the pharmaceutical industry presents another leading water consumer and therefore reduction of water wastes should be at the top of the agenda regarding sustainability

    The Rise of Personalized Medicine in Europe: Opportunities and Challenges for Pharma Companies

    In Europe there is a growing momentum around personalized medicine an inventive method that customizes medical treatments based on individual characteristics As progress in genomics and molecular diagnostics advances

    The FDA May Be Coming Unannounced to Your Facility: Are You Ready?

    On May the President of the United States signed an executive order with far reaching impact on several agencies including the FDA Among other directives beginning in August the US Food and Drug Administration FDA will initiate unannounced inspections at nonUS manufacturing facilities involved in producing drugs biologics medical devices and diagnostics intended for American consumers and patie...

    Generative AI in Pharma: Scaling Productivity without Compromising

    Most enterprise technologies enter a pharmaceutical company through a single door A manufacturing execution system arrives at a site A clinical data platform arrives in development Governance follows the deployment because there is a deployment to govern Generative AI did not behave this way It reached medical writers regulatory managers safety officers market access teams and commercial staff sim...

    What Is Clinical Pharmacology and Its Importance for Drug Development and Patient Care

    Clinical pharmacology is the critical interface between laboratory science and the education of patients Put simply it is the science that researches the interaction of drugs with the human body and the reaction of the latter to drugs People pose the question what is clinical pharmacology The solution can be found in its multidisciplinary character of the matter combining pharmacology medicine ge...

TOP ARTICLES

press releases Read more...

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Telix Pharmaceuticals Limited today announced completion of patient enrollment in the Phase BiPASS study of its commercial PSMAPET imaging agents Illuccix kit for the preparation of gallium

AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer

AstraZeneca today announced the successful completion of the previously announced exclusive license agreement with Dizal Pharmaceutical Co Ltd for ZEGFROVY sunvozertinib an oral irreversible epidermal

BioMed X Relocates Global Headquarters to Heidelberg Innovation Park (hip) and Enters Partnership with BioLabs

BioMed X a leading innovation engine for pharma today announced the relocation of its global headquarters to LAB at Heidelberg Innovation Park hip together with the launch of a global partnership with BioLabs a leading provider of shared laboratory infrastructure for life science innovators

11th Edition Medical Device Project and Portfolio Management

Medical device organizations are under increasing pressure to deliver more innovation with fewer resources while navigating regulatory complexity rising development costs portfolio congestion and growing demands

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

28 - 01

Sep 2026

LATEST NEWS Read more...

Styx Biotechnologies and ZoeNCure Therapeutics Sign Strategic Agreement to Advance ADC Pipeline

Styx Biotechnologies a San Diegobased biotechnology company developing nextgeneration antibodydrug conjugates ADCs for solid tumours has entered into a strategic agreement with ZoeNCure Therapeutics Pvt Ltd to advance selected ADC programmes towards firstinhuman clinical trials

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Expands Executive Leadership Team

Vertex Pharmaceuticals Incorporated Nasdaq VRTX has completed its acquisition of Crinetics Pharmaceuticals Inc Nasdaq CRNX a pharmaceutical company focused on developing treatments for endocrine diseases Vertex has also expanded its executive leadership team as it continues to grow and diversify its...

Eclipsebio Launches Nanopore-Based Assay for Multi-Attribute RNA Characterisation

Eclipse Bioinnovations Inc Eclipsebio a provider of sequencingbased analytics and AIenabled design for RNA therapeutics has launched eSTRAND RNA QC a nanoporebased assay designed to provide multiattribute RNA characterisation

4basebio and Genezen Expand Collaboration on Synthetic DNA for Viral Vector Manufacturing

basebio PLC a specialist in enzymatically produced cellfree DNA for genetic medicines has expanded its collaboration with viral vector contract development and manufacturing organisation CDMO Genezen

Cronus Pharma Launches FDA-Approved Bioequivalent R

Cronus Pharma LLC has launched Robenacoxib Injection in the US offering an FDAapproved bioequivalent to ONSIOR robenacoxib Injection for veterinary use

Artis BioSolutions Launches mRNA and LNP Manufacturing Centre in Bilbao, Spain

Artis BioSolutions has launched its Genetic Medicines Centre of Excellence in Bilbao Spain expanding its development and manufacturing capabilities for genetic medicines